Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date

… Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date …

Researchers Present Significant Trial Results During WCLC 2022

Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines

Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A With Dr. Benjamin Movsas

… Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A …

Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating Cancer

… microbiome in immunotherapy efficacy. … Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating …

IASLC WCLC 2017 Presidential Symposium Presents Leading Lung Cancer Research

… 2017 Presidential Symposium Presents Leading Lung Cancer Research …

First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology

… First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology …

Celebrate 5 Decades of the World Conference on Lung Cancer in San Diego’s Historic Gaslamp Quarter

… Dig out your bell bottoms. Search out your leg warmers. Find your flannel. Whether you … honoring the past and embracing the future of lung cancer research and treatment can be purchased when you  register for …

Spotlight on the WCLC 2025 Talent Showcase

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …